Discover and read the best of Twitter Threads about #virologyblog
Most recents (2)
In this thread, I describe a study that compares SARS-CoV-2 vaccine induced antibody immunity to that induced by COVID-19. Also at #virologyblog. (1/n)
virology.ws/2021/07/01/dyn…
virology.ws/2021/07/01/dyn…
Vaccination against the vaccine-preventable diseases is preferable to natural infection because it prevents illness and the long-term effects associated with many infections; and in most cases, it also leads to better immunity. (2/n)
In the case of immunity induced by SARS-CoV-2 vaccination, it is slowly becoming clear that the immunity is of overall better quality than that induced by COVID-19. (3/n)
Questions about the Johnson & Johnson vaccine? In this post, I describe the composition of the vaccine, the clinical trial results, and how it compares to the other vaccines in use. Also at #virologyblog. (1/n)
virology.ws/2021/03/04/one…
virology.ws/2021/03/04/one…
On February 27, 2021, the FDA issued an emergency use authorization for a third SARS-CoV-2 vaccine. The vaccine was developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson, in collaboration with Beth Israel Deaconess Medical Center in Boston. (2/n)
Perhaps the most exciting feature of this new vaccine is that it only requires one dose to be effective in inducing an immune response. (3/n)
